Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.68 Billion CNY | 14.87% |
| 2022 | 11.91 Billion CNY | 29.71% |
| 2021 | 9.18 Billion CNY | 28.18% |
| 2020 | 7.16 Billion CNY | 60.49% |
| 2019 | 4.46 Billion CNY | 20.77% |
| 2018 | 3.69 Billion CNY | 130.72% |
| 2017 | 1.6 Billion CNY | 28.65% |
| 2016 | 1.24 Billion CNY | 22.47% |
| 2015 | 1.01 Billion CNY | 55.27% |
| 2014 | 655.18 Million CNY | 24.99% |
| 2013 | 524.21 Million CNY | 24.92% |
| 2012 | 419.62 Million CNY | -13.86% |
| 2011 | 487.12 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 16.53 Billion CNY | 6.46% |
| 2024 Q1 | 15.09 Billion CNY | 10.26% |
| 2024 Q2 | 15.52 Billion CNY | 2.89% |
| 2023 Q3 | 11.91 Billion CNY | 5.56% |
| 2023 Q4 | 13.68 Billion CNY | 14.88% |
| 2023 FY | 13.68 Billion CNY | 14.87% |
| 2023 Q1 | 11.77 Billion CNY | -1.2% |
| 2023 Q2 | 11.28 Billion CNY | -4.12% |
| 2022 Q4 | 11.91 Billion CNY | 13.86% |
| 2022 Q3 | 10.46 Billion CNY | 10.1% |
| 2022 Q1 | 9.14 Billion CNY | -0.44% |
| 2022 Q2 | 9.5 Billion CNY | 3.94% |
| 2022 FY | 11.91 Billion CNY | 29.71% |
| 2021 Q1 | 8.48 Billion CNY | 18.31% |
| 2021 Q4 | 9.18 Billion CNY | 14.46% |
| 2021 Q3 | 8.02 Billion CNY | -4.56% |
| 2021 FY | 9.18 Billion CNY | 28.18% |
| 2021 Q2 | 8.41 Billion CNY | -0.82% |
| 2020 Q1 | 4.86 Billion CNY | 8.83% |
| 2020 FY | 7.16 Billion CNY | 60.49% |
| 2020 Q3 | 6.32 Billion CNY | 4.57% |
| 2020 Q4 | 7.16 Billion CNY | 13.3% |
| 2020 Q2 | 6.05 Billion CNY | 24.47% |
| 2019 FY | 4.46 Billion CNY | 20.77% |
| 2019 Q4 | 4.46 Billion CNY | 21.64% |
| 2019 Q3 | 3.67 Billion CNY | 1.44% |
| 2019 Q2 | 3.61 Billion CNY | -1.98% |
| 2019 Q1 | 3.69 Billion CNY | -0.15% |
| 2018 Q2 | 1.71 Billion CNY | -5.4% |
| 2018 Q4 | 3.69 Billion CNY | 26.04% |
| 2018 Q3 | 2.93 Billion CNY | 71.03% |
| 2018 Q1 | 1.81 Billion CNY | 13.14% |
| 2018 FY | 3.69 Billion CNY | 130.72% |
| 2017 Q1 | 1.19 Billion CNY | -4.07% |
| 2017 FY | 1.6 Billion CNY | 28.65% |
| 2017 Q4 | 1.6 Billion CNY | 11.47% |
| 2017 Q3 | 1.43 Billion CNY | 21.56% |
| 2017 Q2 | 1.18 Billion CNY | -1.02% |
| 2016 Q3 | 1.19 Billion CNY | 6.37% |
| 2016 Q2 | 1.12 Billion CNY | 13.76% |
| 2016 Q1 | 990.35 Million CNY | -2.65% |
| 2016 FY | 1.24 Billion CNY | 22.47% |
| 2016 Q4 | 1.24 Billion CNY | 3.97% |
| 2015 Q1 | 745.09 Million CNY | 13.72% |
| 2015 Q4 | 1.01 Billion CNY | 7.08% |
| 2015 Q3 | 950.06 Million CNY | 36.28% |
| 2015 Q2 | 697.16 Million CNY | -6.43% |
| 2015 FY | 1.01 Billion CNY | 55.27% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 655.18 Million CNY | 24.99% |
| 2014 Q2 | 520.39 Million CNY | 0.0% |
| 2014 Q4 | 655.18 Million CNY | 0.0% |
| 2013 FY | 524.21 Million CNY | 24.92% |
| 2012 FY | 419.62 Million CNY | -13.86% |
| 2011 FY | 487.12 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 842.28 Million CNY | -1525.285% |
| Jointown Pharmaceutical Group Co., Ltd | 63.06 Billion CNY | 78.294% |
| LBX Pharmacy Chain Joint Stock Company | 14.89 Billion CNY | 8.095% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 7.1 Billion CNY | -92.692% |